About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker NRIX

Latest patent grants
GrantedPatentOwnerTypeSource
Jun 16, 202612653809
Urea, amide, and substituted heteroaryl compounds for CBL-B inhibition
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Apr 14, 202612600732
Bifunctional compounds for degrading BTK via ubiquitin proteosome pat…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Apr 7, 202612594263
CBL inhibitors and compositions for expansion of immune cells
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Mar 24, 202612583862
Bifunctional compounds for degrading BTK via ubiquitin proteosome pat…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Mar 24, 202612582722
Bifunctional compounds for degrading BTK via ubiquitin proteosome pat…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Mar 10, 202612570662
Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of in…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Jan 20, 202612528814
Bifunctional degraders of interleukin-1 receptor-associated kinases a…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Dec 2, 202512485144
3-substituted piperidine compounds for Cbl-b inhibition, and use ther…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Aug 5, 202512377106
Piperidinylpyrazine-carboxamide compounds for treating and preventing…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Feb 25, 202512234230
Substituted benzyl-triazole compounds for Cbl-b inhibition, and furth…
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗
Oct 22, 202412121540
CBL inhibitors and compositions for use in adoptive cell therapy
NRIX
Nurix Therapeutics, Inc.
utilityGoogle Patents ↗

11 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:05 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances